Results and discussion

E ffect ofviral RNA and eukaryotic mRNA on amino acid incorporation
Addition of either RLV-RNA or MTV-RNA to the cell-free system of E. coli resulted in a significant stimulation of the amino acid incorporation (table 1) . When equal amounts of RLV-and MTV-RNA were tested, the stimulatory effect of the latter was always more pronounced. An even higher stimulation could be obtained if instead of total RLV-RNA the purified 60 S RNA component was added to the system. This is probably. due to an inhibitory effect of the low molecular weight viral RNA (4-5 S), present in the virion, on the translation of 60 S RLV-RNA. Evidence for this assumption was derived from the fact that this low molecular weight RNA fraction also inhibited the translation of phage M12 RNA (cf. [26] ). Denaturation of RLV-RNA consistently resulted in an additional stimulation of the amino acid incorporation, while denaturation of MTV-RNA was much less effective. For comparison the effect of several distinct eukaryotic mRNA prepa rations on the amino acid incorporation was studied. Addition of globin 9 S mRNA resulted in a stimulation of the amino acid incorporation which could be enhanc ed by denaturation. The effect of lens 14 S mRNA, coding for the A2 -chain of a-crystallin, was almost negligible. No significant stimulation could be observed after addition of either 18 S or 28 S ribosomal RNA to the cell-free system.
Analysis o f the in vitro products by SDS polyacrylamide gel electrophoresis
From the results presented in fïg. 1 A it can be concluded that addition of native RLV-RNA to the cellfree system gives rise to the synthesis of a number of distinct polypeptides. Co-electrophoresis of these polypeptides with the proteins derived from the virion indicated that at least those migrating in the low molec ular weight range (slice no. 52-71) coincide with the native viral proteins ( fig. 1 B) . Furthermore additional polypeptides are synthesized which migrate in the 30,000 dalton region (slice no. 32-40). The effect of denaturation of RLV-RNA on the translation is striking. This resulted in the appearance of a high molec ular weight polypeptide (slice no. 2 4 -2 7 ) which is only present in trace amounts in the control experi ment. In order to obtain more accurate data about the size and number of the synthesized polypeptides, autoradiographic analysis on dried gels was performed. In fig. 2 A, the autoradiogram of the polypeptides syn thesized under the direction of denatured RLV-RNA is shown (b). For comparison, the gel pattern of labeled viral proteins is also depicted (c). It may be concluded that denatured RLV-RNA mainly gives rise to the synthesis of two polypeptides, RE0 and RE2 , with molecular weights of approx. 45,000 and 15,000 daltons, respectively. The electrophoretic mobility of the polypeptide RE2 is identical to that of the native protein R2. It might be possible that the polypeptide RE0 is identical to one of the minor viral proteins present in the 45,000 daltons region. No clear indication could be obtained whether a polypeptide of the same size as the viral protein Ri (gs 1) was synthesized. Further more several faint bands are visible of which at least some seem to have no corresponding polypeptide syn- thesized in the endogenous system. As the RNA present in the RLV virion consists of several RNA species, experiments were performed to investigate whether there exists a' difference between the polypeptides synthesized under the direction of total RNA and the purified 60 S RNA component. Analysis of the in vitro products showed that both RNA preparations directed the synthesis of the same polypeptides ( fig. 2 B , a-c). From these results it may be concluded that the RNA component sedimenting in the 60 S region contains all the genetic information necessary to code for the polypeptides synthesized in the in vitro system.
Evidence for the reliability of the in vitro translation of RLV-RNA can be derived from the observation that under direction of RNA isolated from the nonrelated mouse mammary tumor virus (MTV) quite dif ferent polypeptides are synthesized. MTV-RNA directs the synthesis of at least one polypeptide MEt which coincides with one of the native MTV proteins (P6), ( fig. 3 A, a-c). This polypeptide migrates slightly faster than the RLV-RNA directed polypeptide RE2. Denaturation of MTV-RNA does not result in the syn thesis of an additional polypeptide (c) as has been observed in the case of RLV-RNA (f). There is a striking discrepancy between the distribution of radioactivity of polypeptides synthesized under the direction of MTV-RNA as compared with those synthesized under the direction of RLV-RNA (compare b, c with e and f). Furthermore, in case of MTV-RNA a pronounced synthesis of polypeptides which migrated with the buffer-front could be observed (b, c) . The reason for this may be that, although there is a high rate of initiation, the completion of polypeptides is inefficient.
In order to examine whether eukaryotic mRNA preparations are faithfully translated we studied the effect of addition of a-crystallin 14 S and globin 9 S mRNA to the E. coli cell-free system. From fig. 3 B it may be concluded that both mRNA fractions do not give rise to the synthesis of their encoded proteins (b-e). Only low molecular wèight polypeptides seem to be synthesized. As suggested above this may be due to the fact that proteins are initiated but, for reasons still unknowh, not completed. In this connection it should be mentioned that under conditions in which globin-and a-crystallin-mRNA are translated very efficiently in a reticulocyte cell-free system and in oocytes, until now in both systems no evidence could be obtained for the translation of RLV-RNA (experiments in collaboration with Dr. J.B. Gurdon, Unpublished). In the reticulocyte system only a strong inhibition of globin synthesis, up to 85%, could be observed. Although a 0.5 M KCl-wash derived from polysomes of leukemie spleens stimulated the endogenous globin and a-crystallin synthesis, no indication could be ob tained whether this fraction has a positive effect on the translation of RLV-RNA as well.
From our results the conclusion seems to be justifïed that in the cell-free system of E. coli under the direction of the different viral RNA preparations tested at least some virus-specific polypeptides are synthesized. No specifïc polypeptides, however, are synthesized when this cell-free system is programmed with eukaryotic mRNA's.
All the RNA tumour viruses contain an enzyme that transcribes RNA to DNA (Schlom e t a l., 1971a). This finding provides direct evidence for Temin's hypothesis that RNA tumour viruses need a DNA intermediate for virus replication (Temin, 1964) . Synthesis of new DNA, possibly virus-specific, appears in the cytoplasm of cells within a short time after infection (Hatanaka e t a l., 1971) . Chronically infected cells do not show such a DNA syn thesis. Whether the newly-formed DNA becomes integrated in the host cell genome remains to be determined.
An RNA-dependent DNA polymerase has been detected in lymphoblasts of patients with acute and chronic lymphoblastic leukaemia (Gallo e t a l., 1970, and Penner e t a l., 1971). DNA polymerase activity seems to be present in a particulate fraction of plasma from patients with chronic lymphatic leukaemia (Kiessling e t a l., 1971). Reserve transcriptase activities have also been observed in a cell line derived from leukocytes of a patiënt with a myeloid leukaemia (Ackermann e t a l., 1971) and in virus-like particles isolated from human milk (Schlom  e t a l., 19716) .
In v itro the RNA-dependent DNA poly merase can be inhibited partly by rifampicin and to a much greater extent by rifampicin derivatives, with modified aminopiperazine side chains and streptovaricins (Gallo e t a l., 1970; Gurgo e t al., 1971 ; Broekman e t a l., 1971). Rather contradictory results have been published concerning the effect of rifampicin and rifampicin derivatives on virus production and cell transformation after infection of tissue culture cells with an RNA tumour virus (Diggelmann and Weissmann, 1969; Robinson and Robinson, 1971; Richert and Balduzzi, 1971 ; Calvin e t a l., 1971; Carter e t al., 1971 ; Lancini e t a l., 1971). This article describes the inhibitory effect of rifampicin on Rauscher-virus-induced leukaemia in vitro. The Rauscher virus elicits primarily a rapid proliferation of erythroblastic elements which results in spleen enlargement. The rate of splenomegaly can be used as an indicator of the progression of the disease (Rauscher and Allen, 1964). Drug-induced inhibition of spleen enlargement can be considered as an easily-detectable manifestationof a therapeutic effect (Chirigos, 1963) .
MATERIAL A N D METHODS
In all experiments mentioned below, 3-weekold random-bred female Swiss mice were used. Mice were infected intraperitoneally with 0.1 ml of a 10% spleen homogenate as described before (Burghouts e t a l., 1970) . Unless otherwise indicated, treatment with rifampicin commenced 7 days after infection. Rifampicin powder (Lepetit, Milan, Italy) in various amounts as described in the " Results " section was mixed with 2.5 g of pulverized mouse feed granules per mouse. Control animals received the same amount of feed. Mice were killed 4 weeks after infection, i.e., 3 weeks after commencing treat ment. The spleen weight was determined immediately.
RESULTS
The relation between spleen weight and appropriate time intervals after infection is demonstrated in Figure 1 . Already 7 days after infection a marked increase in spleen weight can be observed. This means that treatment was started when all mice had overt leukaemia.
The results of some experiments performed with rifampicin are given in Table I . It can be seen from this Table that administration of 5 mg of rifampicin, 7 days after Rauscher virus infection, results in a reduction of spleen enlargement of 61.7%. This experiment was repeated five times. In all these different experiments the inhibitory effect of the drug (approximately 50-60%) was obvious. The inhibition of spleen enlargement is even more pronounced when treatment is started 4 days (85.1%) or immedi ately (90.3%) after infection. We have evidence that pretreatment of the mice with rifampicin for 7 days does not result in an enhanced effect.
The inhibitory effect of rifampicin depends on the amount of the drug used in each exper iment (Fig. 2) . A higher concentration finally results in a lower spleen weight. The drug con centration generally used (5 mg rifampicin/ mouse/24 h) was not toxic since uninfected d a y s a f t e r infection F ig u r e 1
Relation between spleen weight and tim e after infection
Random-bred Swiss mice were infected with the Rauscher virus as described in the text. control animals which were treated similarly had exactly the same spleen weights and body weights as the untreated control mice. In mice the LD50 of the drug per os was approximately 1,400 mg/kg body weight (Gruppo Lepetit S.p.A. Milan, Italy, unpublished results). In our experiments 1,250 mg/kg body weight given in a single dose orally and mixed with food was not lethal. For comparison, the effect of tetra cycline was also studied. The latter treatment did not reveal any inhibitory effect. 
Relation between spleen weight and rifampicin concentration during treatm ent
Four groups o f random-bred Swiss mice were infected with the Rauscher virus as described in the text. 
DISCUSSION
The influence of rifampicin (an inhibitor of the RNA-dependent DNA polymerase in vitro) on the development of Rauscher-virus-induced leukaemia in vivo was studied. The drug displayed an inhibitory effect which was more pronounced when treatment was started immediately after virus infection. This effect can be explained by the assumption that rifampicin prevents the infection of (previously) uninfected cells. Cells already involved in virus production and transformation may not be sensitive to the drug. This means that rifampicin inhibits either an early event, necessary for virus replication and cell transformation, i.e., it blocks the reverse transcriptase (thus preventing provirus DNA formation) or it prevents some of the sequences leading to the fixation of the provirus DNA in the host cell genome (Richert and Balduzzi, 1971) . Apparently in our experiments the rifampicin block does not seem to be absolute since complete inhibition could not be obtained. This may be explained by the fact that rifampicin itself is not a potent inhibitor of the RNAdependent DNA polymerase in vitro (Gallo et al., 1970; Gurgo et al., 1971) . Furthermore the route of administration (mixing with food) probably does not result in optimal serum rifampicin levels during the full 24 h. More potent inhibitors of reverse transcriptase AF/AP, AF/ABP and AF/ABDP could be tested only in rather low concentrations. The preliminary results of these experiments indeed indicate an inhibitory effect.
As the inhibitory effect of rifampicin in vitro is rather low, our results obtained with the drug in vivo are surprising. Experiments performed with streptovaricins, which are more potent inhibitors of the reverse transcriptase (Broekman et al., 1971; Carter et al., 1971) , resulted in an inhibition of spleen enlargement only for approximately 20% when administered 8 days after infection (Borden et al., 1971) . This result may probably be ascribed to the low absorption rate of the streptovaricin complex when administered orally and the duration of the treatment (one week). Serum levels of 1-3 /ig/ml can be obtained with 1,500 mg strep tovaricin complex/kg body weight/24 h. In our experiments with 5 mg rifampicin/mouse/ 24 h (approximately 250 mg/kg body weight/ 24 h) we obtained serum levels of 100yug/ml. Our results also admit an alternative explanation recently proposed by Vaheri and Hanafusa (1971) . The authors suggest that rifampicin may be more toxic to transformed cells than to normal cells.
If the effect observed is as selective as it seems to be, then it may have important implications for a rational leukaemia therapy.
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